vs
Side-by-side financial comparison of Essent Group Ltd. (ESNT) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $312.4M, roughly 2.0× Essent Group Ltd.). Essent Group Ltd. runs the higher net margin — 49.6% vs 3.3%, a 46.3% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs -0.8%). Essent Group Ltd. produced more free cash flow last quarter ($848.7M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 2.3%).
Essentra PLC is a supplier of plastic and fibre products. The company operates internationally from headquarters in Kidlington, Oxfordshire. It is listed on the London Stock Exchange.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
ESNT vs HIMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $312.4M | $617.8M |
| Net Profit | $155.0M | $20.6M |
| Gross Margin | — | 71.9% |
| Operating Margin | 59.1% | 1.5% |
| Net Margin | 49.6% | 3.3% |
| Revenue YoY | -0.8% | 28.4% |
| Net Profit YoY | -7.7% | -20.8% |
| EPS (diluted) | $1.61 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $312.4M | $617.8M | ||
| Q3 25 | $311.8M | $599.0M | ||
| Q2 25 | $319.1M | $544.8M | ||
| Q1 25 | $317.6M | $586.0M | ||
| Q4 24 | $315.0M | $481.1M | ||
| Q3 24 | $316.6M | $401.6M | ||
| Q2 24 | $312.9M | $315.6M | ||
| Q1 24 | $298.4M | $278.2M |
| Q4 25 | $155.0M | $20.6M | ||
| Q3 25 | $164.2M | $15.8M | ||
| Q2 25 | $195.3M | $42.5M | ||
| Q1 25 | $175.4M | $49.5M | ||
| Q4 24 | $167.9M | $26.0M | ||
| Q3 24 | $176.2M | $75.6M | ||
| Q2 24 | $203.6M | $13.3M | ||
| Q1 24 | $181.7M | $11.1M |
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 73.8% | ||
| Q2 25 | — | 76.4% | ||
| Q1 25 | — | 73.5% | ||
| Q4 24 | — | 76.8% | ||
| Q3 24 | — | 79.2% | ||
| Q2 24 | — | 81.3% | ||
| Q1 24 | — | 82.4% |
| Q4 25 | 59.1% | 1.5% | ||
| Q3 25 | 63.9% | 2.0% | ||
| Q2 25 | 72.4% | 4.9% | ||
| Q1 25 | 65.2% | 9.9% | ||
| Q4 24 | 61.9% | 3.9% | ||
| Q3 24 | 65.6% | 5.6% | ||
| Q2 24 | 76.4% | 3.5% | ||
| Q1 24 | 71.6% | 3.6% |
| Q4 25 | 49.6% | 3.3% | ||
| Q3 25 | 52.7% | 2.6% | ||
| Q2 25 | 61.2% | 7.8% | ||
| Q1 25 | 55.2% | 8.4% | ||
| Q4 24 | 53.3% | 5.4% | ||
| Q3 24 | 55.6% | 18.8% | ||
| Q2 24 | 65.1% | 4.2% | ||
| Q1 24 | 60.9% | 4.0% |
| Q4 25 | $1.61 | $0.08 | ||
| Q3 25 | $1.67 | $0.06 | ||
| Q2 25 | $1.93 | $0.17 | ||
| Q1 25 | $1.69 | $0.20 | ||
| Q4 24 | $1.59 | $0.10 | ||
| Q3 24 | $1.65 | $0.32 | ||
| Q2 24 | $1.91 | $0.06 | ||
| Q1 24 | $1.70 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $228.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.8B | $540.9M |
| Total Assets | $7.4B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $228.6M | ||
| Q3 25 | — | $345.8M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | — | $220.6M | ||
| Q3 24 | — | $165.5M | ||
| Q2 24 | — | $129.3M | ||
| Q1 24 | — | $105.2M |
| Q4 25 | $5.8B | $540.9M | ||
| Q3 25 | $5.7B | $581.0M | ||
| Q2 25 | $5.7B | $562.7M | ||
| Q1 25 | $5.7B | $549.3M | ||
| Q4 24 | $5.6B | $476.7M | ||
| Q3 24 | $5.6B | $440.1M | ||
| Q2 24 | $5.4B | $362.0M | ||
| Q1 24 | $5.2B | $344.5M |
| Q4 25 | $7.4B | $2.2B | ||
| Q3 25 | $7.4B | $2.2B | ||
| Q2 25 | $7.2B | $1.9B | ||
| Q1 25 | $7.2B | $891.7M | ||
| Q4 24 | $7.1B | $707.5M | ||
| Q3 24 | $7.1B | $602.3M | ||
| Q2 24 | $6.7B | $480.5M | ||
| Q1 24 | $6.6B | $448.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $856.1M | $61.3M |
| Free Cash FlowOCF − Capex | $848.7M | $-2.5M |
| FCF MarginFCF / Revenue | 271.7% | -0.4% |
| Capex IntensityCapex / Revenue | 2.4% | 10.3% |
| Cash ConversionOCF / Net Profit | 5.52× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $1.5B | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $856.1M | $61.3M | ||
| Q3 25 | $215.9M | $148.7M | ||
| Q2 25 | $189.5M | $-19.1M | ||
| Q1 25 | $221.6M | $109.1M | ||
| Q4 24 | $861.5M | $86.4M | ||
| Q3 24 | $229.2M | $85.3M | ||
| Q2 24 | $188.7M | $53.6M | ||
| Q1 24 | $216.9M | $25.8M |
| Q4 25 | $848.7M | $-2.5M | ||
| Q3 25 | $210.6M | $79.3M | ||
| Q2 25 | $188.8M | $-69.5M | ||
| Q1 25 | $221.3M | $50.1M | ||
| Q4 24 | $854.8M | $59.5M | ||
| Q3 24 | $228.7M | $79.4M | ||
| Q2 24 | $187.6M | $47.6M | ||
| Q1 24 | $212.5M | $11.8M |
| Q4 25 | 271.7% | -0.4% | ||
| Q3 25 | 67.5% | 13.2% | ||
| Q2 25 | 59.2% | -12.8% | ||
| Q1 25 | 69.7% | 8.5% | ||
| Q4 24 | 271.3% | 12.4% | ||
| Q3 24 | 72.2% | 19.8% | ||
| Q2 24 | 60.0% | 15.1% | ||
| Q1 24 | 71.2% | 4.3% |
| Q4 25 | 2.4% | 10.3% | ||
| Q3 25 | 1.7% | 11.6% | ||
| Q2 25 | 0.2% | 9.3% | ||
| Q1 25 | 0.1% | 10.1% | ||
| Q4 24 | 2.1% | 5.6% | ||
| Q3 24 | 0.2% | 1.5% | ||
| Q2 24 | 0.3% | 1.9% | ||
| Q1 24 | 1.5% | 5.0% |
| Q4 25 | 5.52× | 2.98× | ||
| Q3 25 | 1.31× | 9.43× | ||
| Q2 25 | 0.97× | -0.45× | ||
| Q1 25 | 1.26× | 2.20× | ||
| Q4 24 | 5.13× | 3.32× | ||
| Q3 24 | 1.30× | 1.13× | ||
| Q2 24 | 0.93× | 4.03× | ||
| Q1 24 | 1.19× | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESNT
| Mortgage Insurance Segment | $192.4M | 62% |
| Other | $120.0M | 38% |
HIMS
Segment breakdown not available.